HK36693A - Use of ketone derivatives in the treatment of cognitive disorders - Google Patents
Use of ketone derivatives in the treatment of cognitive disordersInfo
- Publication number
- HK36693A HK36693A HK366/93A HK36693A HK36693A HK 36693 A HK36693 A HK 36693A HK 366/93 A HK366/93 A HK 366/93A HK 36693 A HK36693 A HK 36693A HK 36693 A HK36693 A HK 36693A
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- cognitive disorders
- ketone derivatives
- ketone
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630075A GB8630075D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878726424A GB8726424D0 (en) | 1987-11-11 | 1987-11-11 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
HK36693A true HK36693A (en) | 1993-04-23 |
Family
ID=26291706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK366/93A HK36693A (en) | 1986-12-17 | 1993-04-15 | Use of ketone derivatives in the treatment of cognitive disorders |
Country Status (15)
Country | Link |
---|---|
US (1) | US4845115A (el) |
EP (1) | EP0275668B1 (el) |
JP (1) | JP2608078B2 (el) |
KR (1) | KR950013450B1 (el) |
AU (1) | AU618520B2 (el) |
CY (1) | CY1692A (el) |
DE (1) | DE3782028T2 (el) |
DK (1) | DK662687A (el) |
ES (1) | ES2052585T3 (el) |
GR (1) | GR3006255T3 (el) |
HK (1) | HK36693A (el) |
IE (1) | IE60991B1 (el) |
IL (1) | IL84845A0 (el) |
NZ (1) | NZ222950A (el) |
PH (1) | PH25025A (el) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
GB8805269D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
US5229407A (en) * | 1988-09-01 | 1993-07-20 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
EP0591395A1 (en) * | 1991-06-26 | 1994-04-13 | Sepracor, Inc. | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
JPH08507514A (ja) * | 1993-03-08 | 1996-08-13 | 藤沢薬品工業株式会社 | 脳血管性疾患を治療または予防するための薬物 |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
ATE285235T1 (de) * | 1999-01-07 | 2005-01-15 | Gerolymatos P N Sa | Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund |
WO2000051582A2 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
GB0701970D0 (en) | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
FR2557110B1 (fr) * | 1983-12-23 | 1989-11-24 | Sandoz Sa | Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments |
FI84349C (fi) * | 1984-01-25 | 1991-11-25 | Glaxo Group Ltd | Foerfarande foer framstaellning av en farmakologiskt vaerdefull foerening. |
DE3680123D1 (en) * | 1985-01-23 | 1991-08-14 | Glaxo Group Ltd | Tetrahydrocarbazolonderivate. |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
DE3688296T2 (de) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | Arzneimittel zur behandlung von erbrechen. |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
-
1987
- 1987-12-16 PH PH36242A patent/PH25025A/en unknown
- 1987-12-16 ES ES87311078T patent/ES2052585T3/es not_active Expired - Lifetime
- 1987-12-16 DE DE8787311078T patent/DE3782028T2/de not_active Expired - Lifetime
- 1987-12-16 US US07/133,884 patent/US4845115A/en not_active Expired - Lifetime
- 1987-12-16 JP JP62318456A patent/JP2608078B2/ja not_active Expired - Lifetime
- 1987-12-16 NZ NZ222950A patent/NZ222950A/en unknown
- 1987-12-16 EP EP87311078A patent/EP0275668B1/en not_active Expired - Lifetime
- 1987-12-16 DK DK662687A patent/DK662687A/da not_active Application Discontinuation
- 1987-12-16 AU AU82614/87A patent/AU618520B2/en not_active Ceased
- 1987-12-16 IL IL84845A patent/IL84845A0/xx not_active IP Right Cessation
- 1987-12-16 IE IE341487A patent/IE60991B1/en not_active IP Right Cessation
- 1987-12-17 KR KR1019870014391A patent/KR950013450B1/ko not_active IP Right Cessation
-
1992
- 1992-11-16 GR GR920402595T patent/GR3006255T3/el unknown
-
1993
- 1993-04-15 HK HK366/93A patent/HK36693A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169294A patent/CY1692A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL84845A0 (en) | 1988-06-30 |
AU8261487A (en) | 1988-06-23 |
DK662687D0 (da) | 1987-12-16 |
ES2052585T3 (es) | 1994-07-16 |
US4845115A (en) | 1989-07-04 |
IE60991B1 (en) | 1994-09-07 |
JP2608078B2 (ja) | 1997-05-07 |
EP0275668A2 (en) | 1988-07-27 |
EP0275668A3 (en) | 1989-10-11 |
DK662687A (da) | 1988-06-18 |
DE3782028T2 (de) | 1993-02-18 |
GR3006255T3 (el) | 1993-06-21 |
IE873414L (en) | 1988-06-17 |
AU618520B2 (en) | 1992-01-02 |
JPS63253083A (ja) | 1988-10-20 |
EP0275668B1 (en) | 1992-09-30 |
DE3782028D1 (de) | 1992-11-05 |
CY1692A (en) | 1994-01-14 |
KR950013450B1 (ko) | 1995-11-08 |
KR880007074A (ko) | 1988-08-26 |
NZ222950A (en) | 1997-06-24 |
PH25025A (en) | 1991-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA87247B (en) | Treatment of skin disorders | |
GB2190842B (en) | Apparatus for the cryogenic treatment of the skin | |
EP0204597A3 (en) | Use of alfuzosine in the treatment of urinary affections | |
AU6022486A (en) | Apparatus for trichologic treatment of the scalp | |
HK107594A (en) | Treatment of skin disorders | |
HK36693A (en) | Use of ketone derivatives in the treatment of cognitive disorders | |
EP0278173A3 (en) | Use of heterocyclic derivatives in the treatment of depressions | |
PT84704A (en) | Thiolactam-n-acetic derivatives their production and use | |
AU624067B2 (en) | Preparation suitable for use in the treatment of enteric disorders | |
GB2211192B (en) | Composition and process for the treatment and care of the hair | |
GR861024B (en) | Process for the preparation of 5-pyrimidinecarboxamides and treatment of leukemia and tummors therewith | |
EP0235647A3 (en) | Process for the manufacture of 6,13-dihydroquinacridones and quinacridones | |
GB2203645B (en) | Improvements in the treatment of hair | |
GB2176104B (en) | Compositions for treatment of the hair and scalp. | |
GB8626356D0 (en) | Treatment of hair | |
AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
GB8715914D0 (en) | Treatment of cerabral disorders | |
ZA87873B (en) | Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders | |
GB8617623D0 (en) | Treatment | |
EP0407016A3 (en) | Use of benzodioxinopyrrole derivatives in the treatment of anxiety | |
EP0267537A3 (en) | Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use | |
SG4695G (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases | |
GB8432685D0 (en) | Skin treatment cream | |
GB9010190D0 (en) | Composition for the treatment of protozoal disease and their use | |
EP0269024A3 (en) | Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20041216 |